Quality Standards
Now that there are new measurement uncertainty goals, it's time to check if any instruments can hit them. Using the performance data from a recent study of the Roche cobas 8000 series in France, we assess the acceptability of the mu of methods.
One of the disappointments of the 2023 AACC/ADLM was seeing Siemen's benchmark their newest Atellica assays against the oldest CLIA goals.
We look at the impact of new EFLM goals for coagulation assays on the assessment of an Atellica COAG 360.
A recent study of Abbott Alinity thyroid function tests can be evaluated against the EFLM MAU and the preferred permissible uncertainties proposed by the leading authorities on mu.
A recent study of Roche Cobas 8000 chemistry assays in Turkey looks at their measurement uncertainty. We compare the Roche mu against the EFLM MAU and the preferred permissible uncertainties proposed by the leading authorities on mu.